Results 161 to 170 of about 395,238 (233)

Immunogenicity and safety of measles-mumps-rubella vaccine delivered by the aerosol, intradermal and intramuscular routes in previously vaccinated young adults: a randomized controlled trial protocol. [PDF]

PLoS One
Saha S, Millier M, Samaranayaka A, Edmonds L, Best E, Ussher J, Anglemyer A, Lee J, Tatley M, Cutts F, van Binnendijk R, McIntyre P.   +11 more
europepmc   +1 more source

Safety and immunogenicity of Biological E's typhoid conjugate vaccine TYPHIBEV^Ⓡ concomitantly administered with measles rubella vaccine: a phase IV prospective, multicenter study. [PDF]

IJID Reg
Thuluva S, Matur RV, Gunneri S, Mogulla R, Dhar C, Yerroju V, Balne N, Chakravarthy BS, Narang M, Mahantshetti NS, Pandey AK.   +10 more
europepmc   +1 more source

Measles, mumps, and rubella vaccine at age 6 months and hospitalisation for infection before age 12 months: randomised controlled trial.

BMJ, 2023
Zimakoff AC, Jensen A, Vittrup DM, Herlufsen EH, Sørensen JK, Malon M, Svensson J, Stensballe LG.   +7 more
europepmc   +1 more source

Measles & Rubella Initiative annual report 2013

The Measles and Rubella Initiative (M&RI) is pleased to present our 2013 annual report on the global status of measles and rubella control and elimination.

core  

TikTok content on measles-rubella vaccine in Jordan: A cross-sectional study highlighting the spread of vaccine misinformation. [PDF]

Narra J
Abdaljaleel M, Barakat M, Mahafzah A, Hallit R, Hallit S, Sallam M.   +5 more
europepmc   +1 more source

Rubella surveillance no. 2, AUGUST 1970

In June 1969, a live attenuated rubella virus vaccine was licensed for use in the United States. Subsequently, two other rubella vaccines have been licensed.

core  

A measles and rubella vaccine microneedle patch in The Gambia: a phase 1/2, double-blind, double-dummy, randomised, active-controlled, age de-escalation trial. [PDF]

Lancet
Adigweme I, Yisa M, Ooko M, Akpalu E, Bruce A, Donkor S, Jarju LB, Danso B, Mendy A, Jeffries D, Segonds-Pichon A, Njie A, Crooke S, El-Badry E, Johnstone H, Royals M, Goodson JL, Prausnitz MR, McAllister DV, Rota PA, Henry S, Clarke E.   +21 more
europepmc   +1 more source

Measles & Rubella Initiative annual report 2014

The Measles and Rubella Initiative (M&RI) is pleased to present its 2014 annual report. This year\ue2\u20ac\u2122s report highlights countries in action as they implement the strategies required to achieve measles and rubella control and elimination.The ...

core